机构:[1]Department of Neurosurgery, The Fourth Hospital of Hebei Medical University.临床科室神经外科河北医科大学第四医院[2]Department of Neurosurgery, The Second Hospital of Hebei Medical University.
Human cytomegalovirus (HCMV) is associated with epithelial-mesenchymal transition (EMT) in glioma cells; however, its underlying action mechanism remain ambiguous. In this study, we investigated the effects of receptor-interacting protein 2 (RIP2) and nuclear factor (NF)-κB on EMT in HCMV-infected glioma LN-18 cells. Wound healing and invasion assays were used to evaluate the migration and invasion of cells. Western blotting and immunofluorescence microscopy were used to determine the protein expression levels. We found that HCMV induced enhanced migration and invasion of LN-18 cells, activation of the RIP2/NF-κB signaling pathway, downregulation of epithelial cell marker (E-cadherin) expression, and upregulation of mesenchymal cell marker (N-cadherin and vimentin) expression. Moreover, inhibition of RIP2 or NF-κB inhibited the induction of HCMV in LN-18 cells. Therefore, HCMV induces EMT in glioma cells by promoting the activation of NF-κB signaling pathway via the upregulation of RIP2 expression.
基金:
This work was supported by the Na-
tional Natural Science Foundation of China (No. 81241076).
第一作者机构:[1]Department of Neurosurgery, The Fourth Hospital of Hebei Medical University.
通讯作者:
推荐引用方式(GB/T 7714):
Cui Kai,Wang Xiaoliang,Han ChengXi,et al.Mechanism of Human Cytomegalovirus-Induced Epithelial-Mesenchymal Transition in Glioma Cells via the Upregulation of RIP2 Expression[J].Biological & pharmaceutical bulletin.2023,46(11):1506-1511.doi:10.1248/bpb.b23-00256.
APA:
Cui Kai,Wang Xiaoliang,Han ChengXi,Liu Shuo&Hu Yuhua.(2023).Mechanism of Human Cytomegalovirus-Induced Epithelial-Mesenchymal Transition in Glioma Cells via the Upregulation of RIP2 Expression.Biological & pharmaceutical bulletin,46,(11)
MLA:
Cui Kai,et al."Mechanism of Human Cytomegalovirus-Induced Epithelial-Mesenchymal Transition in Glioma Cells via the Upregulation of RIP2 Expression".Biological & pharmaceutical bulletin 46..11(2023):1506-1511